Howard Welgus plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144

Howard Welgus filed Form 144 to notify SEC of plan to sell 635 units of Arcutis Biotherapeutics, Inc. securities around 2026-06-17, with aggregate market value of $16,300.45. The total outstanding units is 125083374.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 04/01/2026, sold 10000 units for $238800.00; On 05/01/2026, sold 7144 units for $164219.71; On 06/15/2026, sold 4096 units for $99980.49;